Active ingredient
Oxymorphone
27 finished FDA listings contain Oxymorphone as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- OXYMORPHONE HYDROCHLORIDE
- Dosage forms
- Tablet, Tablet, Film Coated, Extended Release
- Routes
- Oral
- Manufacturers / labelers
- 9
- Strengths listed
- 10 mg/1 · 15 mg/1 · 20 mg/1 · 30 mg/1 · 40 mg/1 · 5 mg/1 · 7.5 mg/1
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 7814
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| ANDA 079087 | IMPAX LABS | 2010-06-14 | 14 |
| ANDA 090964 | HIKMA | 2010-09-27 | 2 |
| ANDA 203601 | AVANTHI INC | 2013-01-30 | 2 |
| ANDA 201187 | EPIC PHARMA LLC | 2014-12-15 | 2 |
| ANDA 204459 | AUROLIFE PHARMA LLC | 2016-04-26 | 2 |
| ANDA 210175 | ASCENT PHARMS INC | 2018-02-02 | 5 |
Official labeling on DailyMed
- OXYMORPHONE HYDROCHLORIDE TABLET [AUROLIFE PHARMA, LLC] · version 16 · 2026-06-30
- OXYMORPHONE HYDROCHLORIDE TABLET [KVK-TECH, INC.] · version 17 · 2026-02-02
- OXYMORPHONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [AMNEAL PHARMACEUTICALS LLC] · version 15 · 2026-01-23
- OXYMORPHONE HYDROCHLORIDE TABLET [HIKMA PHARMACEUTICALS USA INC.] · version 18 · 2025-12-22
- OXYMORPHONE HYDROCHLORIDE TABLET [EPIC PHARMA, LLC] · version 12 · 2025-12-19
- OXYMORPHONE HYDROCHLORIDE TABLET [CAMBER PHARMACEUTICALS, INC] · version 7 · 2025-09-01
- OXYMORPHONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [AMNEAL PHARMACEUTICALS OF NEW YORK LLC] · version 40 · 2024-02-15
- OXYMORPHONE HYDROCHLORIDE TABLET [BRYANT RANCH PREPACK] · version 102 · 2024-01-10
- OXYMORPHONE HYDROCHLORIDE TABLET [XLCARE PHARMACEUTICALS, INC.] · version 1 · 2020-05-08
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.